Sunday, July 26, 2026

Hemlibra Breakthrough: 91% of Hemophilia Patients in Japan Experience No Adverse Reactions!

JW Pharmaceutical's Hemlibra shows 91% safety in Japanese hemophilia patients, with no adverse reactions in long-term study.

LS Electric Wins 2026 GEAN Award: A Leader in Carbon Neutrality and e-Mobility

LS Electric wins the Corporate Grand Prize at the GEAN Awards for its contributions to carbon neutrality and smart energy technology.

AI-Powered Drones: Kim Jong Un’s New ‘Venus’ Series Is a Major Threat to U.S. and Allies

Kim Jong Un inspected unmanned armed equipment, emphasizing military modernization and AI technology in North Korea's defense strategy.

Tag: metabolic effects

DA-2811 vs. Farxiga: Which Diabetes Treatment Proves More Effective in 2026?

Dong-A ST's DA-2811 shows comparable efficacy to Farxiga in diabetes treatment, with positive clinical trial results presented at ADA.

Top News

- Our Sponsors Ad -

Follow us